Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Bayer Acquisition of Roche Health Biz Approved

Approval for Bayer’s acquisition of Roche’s consumer health business

- Bayer HealthCare’s Consumer Care Division to expand in New Zealand

Some of New Zealand’s most popular prescription-free medicines will soon be merged under one company following European Commission approval of Bayer AG’s EUR 2.38 billion acquisition of Roche’s consumer health business.

The global acquisition, which is due to go through in New Zealand early in the new year, will bring together OTC (over the counter) brands such as Bayer Healthcare’s Aspirin® and Canesten® with Roche’s consumer brands, including Berocca® and Aspro®.

As a result, Bayer’s Consumer Care Division in New Zealand will nearly double its brand portfolio.

Integration teams are currently working through the details of the acquisition, which will see Bayer New Zealand increase employee numbers and establish a national sales team for consumer care.

Work is also being done on expected turnover in New Zealand, although figures are not available at this stage.

Globally the combined company is expected to have sales of EUR 2.4 billion and 6700 employees in 120 countries.

Bayer HealthCare’s Managing Director for Australia and New Zealand, Derrill Palidwar, said Bayer was aiming at becoming the world leader in the OTC business.

“The acquisition is an important step towards this goal, particularly as the combined product portfolios are highly complementary and contain strong trusted brands.

“OTC products are a fast developing part of the health care market, one which is characterised by increasing consumer interest in overall health and self-medication. This is a good opportunity for our products.” More… Key Bayer consumer care brands in New Zealand are Aspirin®, Canesten®, Alka Seltzer®, Am-O-Lin® baby care products and the Pluravit® vitamin range.

Main Roche brands in New Zealand are vitamins Berocca®, Supradyn®, Redoxon® and Elevit®, as well as brands Aspro®, Naprogesic®, Cepacol®, Bepanthen® and Ungvita®.

Bayer AG is a German based company with three core business areas – HealthCare, CropScience and MaterialScience. In New Zealand it operates through Bayer New Zealand Ltd, based on Auckland’s North Shore.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Elsewhere:


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>